The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: LIpitor and biGuanide to Androgen Delay Trial
Official Title: A Randomized, Double Blind, Trial of Metformin and Atorvastatin in Delaying Androgen Deprivation Therapy Among Men With Rising PSA Following Radical Prostatectomy or Radiotherapy: The LIGAND (LIpitor and biGuanide to Androgen Delay) Trial
Study ID: NCT02497638
Brief Summary: This study is a randomized trial examining the administration of a combination of biguanide metformin and atorvastatin ("Lipitor") to men who are experiencing rising prostate-specific antigen (PSA) levels, despite having undergone radical therapy (surgery and/or radiation).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Name: Robert Hamilton, MD, MPH, FRCSC
Affiliation: University Health Network, Toronto
Role: PRINCIPAL_INVESTIGATOR
Name: Neil Fleshner, MD, MPH, FRCSC
Affiliation: University Health Network, Toronto
Role: PRINCIPAL_INVESTIGATOR